Neurosteer’s Peer-Reviewed Publication: Evaluation of Parkinson’s Disease Early Diagnosis with Neurosteer’s hdrEEG™ System NEW YORK, Dec. 19, 2023 -- Neurosteer Inc. announces the publication of our groundbreaking paper in Frontiers in Neurology detailing a revolutionary approach to Parkinson's disease detection and differentiation using our pocket-sized hdrEEG™ system and a rapid 15-minute auditory assessment.disorders. The study was performed using Neurosteer’s FDA cleared medical-grade hdrEEG™ system which represents a breakthrough in brain “scanning” and offers a completely novel appro ..read more

Neurosteer to Present at ApplySci MIT | 2023 NEW YORK, Sep. 1, 2023 -- Neurosteer founder and CEO, Nathan Intrator PhD, has been invited to be a main speaker at the ApplySci AI + Deep Tech + NeuroTech conference at MIT later this month. On September 18 at 11:30am, Intrator will demonstrate Neurosteer’s breakthrough hdrEEG™ technology in support of his presentation titled “Brain Wellness and Very Early Detection of Neurodegeneration.” This will be the first time the company presents its connectivity analysis, which has historically been performed by an fMRI. But unlike the room-sized fMRI ..read more

Brain Activity and Music as Seen with Neurosteer’s hdrEEG™ System New York, Jun. 20, 2023 -- In “This Is What Music Does to Your Brain,” Yael Hallak of Haaretz writes that new research is exploring how to use music to bring people closer and even to diagnose cognitive decline in the elderly. The article covers the work of Neurosteer’s Neta Maimon with music and brain activity. Maimon, a PhD and avid musician, has for years been championing the use of auditory stimulation for precise brain activation during the measurement of brain activity using Neurosteer’s hdrEEG™ system. She was recent ..read more

..read more

Neurosteer started a clinical study at Langone Hospital, NYU with Prof. Leigh Charvet, on quantifying the effect of tDCS on Multiple Sclerosis (MS) patients. MS patients receive a frontal lobe stimulation to improve their cognition. Such stimulation is not always effective, and often patients receive 20 stimulation sessions to discover at the end that there was no effect. Neurosteer’s device will assess the effectiveness of the stimulation after one session and this will be correlated with the effect after 20 sessions. Such an assessment can provide an indication of the effectiveness of the t ..read more

Consciousness in Babies  |  Prof Steven Laureys  |  TEDxFlandersWomen ..read more

On February 7, 2017 at Stanford University , Nathan Intrator described Neurosteer at the Wearable Tech + Digital Health + Neurotech conference ..read more

Neurosteer’s EEG System Features Novel Brain Activity Representation Based on Advanced EEG Signal Processing Technology NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Neurosteer Inc. today announced the FDA clearance of its Neurosteer® single-channel EEG brain monitoring platform. This clearance allows Neurosteer’s unobtrusive multi-purpose system to be used in a broad range of clinical settings. In the ICU, it can offer continuous brain monitoring to support critical interventions. In a doctor’s office, it can aid in the early detection of pre-symptomatic cognitive decline, including Alzheimer’s ..read more

http://www.ynet.co.il/video/0,20658,141298-4974311,00.html ..read more

Nathan Intrator was a keynote speaker at yet another Conference by Yandex, May 30, 2017, Moscow ..read more